Page last updated: 2024-08-21

d-alpha tocopherol and Substance Withdrawal Syndrome

d-alpha tocopherol has been researched along with Substance Withdrawal Syndrome in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19903 (23.08)18.7374
1990's2 (15.38)18.2507
2000's4 (30.77)29.6817
2010's3 (23.08)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Cunha, MS; Oesterreich, SA; Paes, MM; Ponsoni, LF; Stefanello da Silveira, AP; Villas Boas, GR1
Agar, E; Ayyildiz, M; Kozan, R; Yildirim, M1
Ito, S; Matsubayashi, K; Mori, T; Sawaguchi, T1
Accinni, R; Cighetti, G; Pinelli, A; Trivulzio, S1
Birdane, Y; Bulut, S; Büyükokuroğlu, ME; Cemek, M; Hazman, Ö; Konuk, M1
Birdane, YO; Bulut, S; Büyükokuroğlu, ME; Cemek, M; Hazman, O; Konuk, M1
Downey, HF; Ju, X; Jung, ME; Mallet, RT; Metzger, DB1
DAVIDIAN, H1
Berger, JL; Renaud, S; Ruf, JC1
Butcher, GP; Jackson, MJ; Krasner, N; Rhodes, JM; Walker, R1
Simpson, GM1
Björk, G; Egberg, N; Hillbom, M; Kangasaho, M; Muuronen, A; Neiman, J1
Borisenko, SA; Burov, IuV1

Reviews

1 review(s) available for d-alpha tocopherol and Substance Withdrawal Syndrome

ArticleYear
The treatment of tardive dyskinesia and tardive dystonia.
    The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 4

    Topics: Adult; Akathisia, Drug-Induced; Algorithms; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Male; Olanzapine; Pirenzepine; Probability; Reserpine; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Tetrabenazine; Treatment Outcome; Vitamin E

2000

Trials

1 trial(s) available for d-alpha tocopherol and Substance Withdrawal Syndrome

ArticleYear
The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification.
    Journal of hepatology, 1993, Volume: 19, Issue:1

    Topics: Adult; Aged; Antioxidants; Ascorbic Acid; beta Carotene; Biomarkers; Carotenoids; Double-Blind Method; Drug Therapy, Combination; Ethanol; Female; Free Radicals; Hematologic Tests; Humans; Liver Diseases, Alcoholic; Male; Middle Aged; Selenium; Substance Withdrawal Syndrome; Vitamin E

1993

Other Studies

11 other study(ies) available for d-alpha tocopherol and Substance Withdrawal Syndrome

ArticleYear
Evaluation of the effect of alpha-tocopherol on anxiety and the neuroinflammatory process during alcohol withdrawal in a model of forced and chronic self-administration of liquid diet containing ethanol: Behavioral and neurochemical evidence.
    Alcohol (Fayetteville, N.Y.), 2022, Volume: 104

    Topics: Alcoholism; alpha-Tocopherol; Animals; Anti-Anxiety Agents; Anxiety; Diet; Ethanol; Male; Rats; Rats, Wistar; Substance Withdrawal Syndrome

2022
The effects of ethanol intake and withdrawal on penicillin-induced epileptiform activity in rats.
    Brain research bulletin, 2006, Dec-11, Volume: 71, Issue:1-3

    Topics: Action Potentials; Alcohol-Induced Disorders, Nervous System; alpha-Tocopherol; Animals; Anticonvulsants; Antioxidants; Brain; Central Nervous System Stimulants; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electroencephalography; Epilepsy; Ethanol; Male; Penicillins; Rats; Rats, Wistar; Substance Withdrawal Syndrome

2006
Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
    Behavioural pharmacology, 2007, Volume: 18, Issue:8

    Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Enzyme Inhibitors; Free Radical Scavengers; Hydroxyl Radical; Male; Mice; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Opioid-Related Disorders; Phospholipase A2 Inhibitors; Substance Withdrawal Syndrome; Superoxides

2007
Morphine or its withdrawal affects plasma malondialdehyde, vitamin E levels and absence or presence of abstinence signs in rats.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:4

    Topics: Animals; Isoproterenol; Male; Malondialdehyde; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Vitamin E

2009
Antioxidant enzyme and element status in heroin addiction or heroin withdrawal in rats: effect of melatonin and vitamin E plus Se.
    Biological trace element research, 2011, Volume: 139, Issue:1

    Topics: Animals; Antioxidants; Heroin Dependence; Male; Melatonin; Rats; Rats, Sprague-Dawley; Selenium; Substance Withdrawal Syndrome; Superoxide Dismutase; Vitamin E

2011
The roles of melatonin and vitamin E plus selenium in prevention of oxidative stress induced by naloxone-precipitated withdrawal in heroin-addicted rats.
    Biological trace element research, 2011, Volume: 142, Issue:1

    Topics: Animals; Antioxidants; Ceruloplasmin; Glutathione; Heroin; Heroin Dependence; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Naloxone; Nitrates; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; Selenium; Substance Withdrawal Syndrome; Vitamin E

2011
Intermittent hypoxia conditioning protects mitochondrial cytochrome c oxidase of rat cerebellum from ethanol withdrawal stress.
    Journal of applied physiology (Bethesda, Md. : 1985), 2012, Volume: 112, Issue:10

    Topics: Alcohol Drinking; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Blotting, Western; Cerebellum; Cytochromes c; Disease Models, Animal; Electron Transport Complex IV; Ethanol; Hypoxia; Imidazoles; Male; Mitochondria; Motor Activity; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Carbonylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Reaction Time; Spectrophotometry; Substance Withdrawal Syndrome; Time Factors; Vitamin E

2012
The treatment of withdrawal symptoms of opium addicts with vitamin E in ten cases.
    Acta medica Iranica, 1957, Volume: 1, Issue:3

    Topics: Humans; Opium; Substance Withdrawal Syndrome; Substance-Related Disorders; Vitamin E

1957
Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Relation to tannins and lipid peroxidation.
    Arteriosclerosis, thrombosis, and vascular biology, 1995, Volume: 15, Issue:1

    Topics: Alcohol Drinking; Animals; Ethanol; Lipid Peroxidation; Lipids; Male; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tannins; Vitamin A; Vitamin E; Wine

1995
Effects of vitamin E therapy on ethanol-induced changes in platelet aggregation, thromboxane formation, factor VIII levels and serum lipids.
    European journal of clinical investigation, 1987, Volume: 17, Issue:1

    Topics: Adult; Alcoholism; Factor VIII; Humans; Lipids; Male; Middle Aged; Platelet Aggregation; Substance Withdrawal Syndrome; Thromboxanes; Vitamin E

1987
[Effect of pharmacological substances on the altered permeability of the hemato-encephalic barrier for 14C-tyrosine due to ethanol].
    Biulleten' eksperimental'noi biologii i meditsiny, 1987, Volume: 103, Issue:1

    Topics: Alcoholism; Animals; Blood-Brain Barrier; Carbon Radioisotopes; Cell Membrane Permeability; Chlorpromazine; Dose-Response Relationship, Drug; Ethanol; Haloperidol; Male; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Tyrosine; Vitamin E

1987